Smad4»ùÒò,Smad4 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á÷ʽϸ°ûѧ,flow cytometryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö±³¦È«ÏµÄ¤ÇгýÊõ,total mesorectal excisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÄÏ׻عË,literature reviewÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹ÜÖ×Áö/ÖÎÁÆ,esophageal neoplasms/therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö±³¦Ö×Áö/·ÅÉäÁÆ·¨,Rectal neoplasms/radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÁÈÀÉú̬»·¾³,soil ecological environmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦µÀ¼äÖÊÁö,gastrointestinal stromal tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔλRT-PCR,in situ RT-PCRÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ëõ϶¯Âö,inferior phrenic arteryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Ö²¿ÇгýÊõ,Local resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Ö²¿Çгý,Local resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ßԵȺ,Side PopulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Áö˨,tumor thrombusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
øϸ°û»¯Ñ§,enzyme cytochemistryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
cDNA»ùÒòоƬ,cDNA microarrayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë¿°±ËáÄÚëÄøÀà,serine endopeptidasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¡×éÖ¯,muscle tissueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇøÓò»¯ÁÆ,Regional chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃɹÅɳÍÁÊó,Mongolian gerbilÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÍâ»ùÖʵ°°×ÖÊÀà,extracellular matrix proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë«ÖØÈ¾É«,double stainingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈýÒ¶Òò×Ó3,Trefoil factor 3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µâȾɫ,iodine stainingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó-C,Vascular endothelial growth factor-CÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁòË᳤´ºÐ¼î,vincristine sulfateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Óγ̼ìÑé,Runs testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°×µ°°×ÄÉÃ×Á£,albumin nanoparticlesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÖÖÆÏû¼õÔÓ½»¼¼Êõ,Suppression subtractive hybridizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Íâ¿ÆÇгý,surgical resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î°©Ç°²¡±ä,precancerous lesion of liverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Raf¼¤Ã¸ÒÖÖÆµ°°×,Raf kinase inhibitor proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
COX-2µ°°×,COX-2 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö½øÕ¹,tumor progressionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
B7-1»ùÒò,B7-1 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏËά×é֯ϸ°ûÁö,fibrous histiocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HT-29ϸ°ûϵ,HT-29 cell lineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚÆ¤Ï¸°ûÌØÒìÐÔ·Ö×Ó-1,Endothelial cell specific molecule-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½áºÏ»îÐÔ,Binding activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÒÅ´«Ñ§·ÖÎö,cytogenetic analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶¯Âö»¯ÁÆ,intra-arterial chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöÐγɹý³Ì,Neoplastic processesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö±³¦Ö×Áö/²¡Àíѧ,rectal neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×ÓÊÜÌå-3,Vascular endothelial growth factor receptor-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
̼ÏËά°å,CFRP plateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆÏÌÑÇò¾ú³¦¶¾ËØ,staphylococcal enterotoxinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËáÐÔ»·¾³,acid environmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶þÏ©±û»ù¶þÁò»¯Îï,diallyl disulfideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»Æ²è,yellow teaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚ·ÖÃÚÏÙÖ×Áö,Endocrine Gland NeoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö΢Ѫ¹ÜÃܶÈ,Microvessel densityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹Ü´²,Esophageal bedÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HMGB1µ°°×,HMGB1 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î×ªÒÆ°©,Hepatic metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×éÖ¯½ðÊôµ°°×øÒÖÖÆ¼Á,tissue inhibitor of metalloproteinaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÜÉú´æÆÚ,Overall survivalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØ¶Îʳ¹Ü°©,thoracic esophageal carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾µ¼¹Ü¶¯Âö˨ÈûÊõ,Transcatheter arterial embolizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾µ¼¹Ü¶¯Âö»¯ÁÆË¨ÈûÊõ,transcatheter arterial chemoembolizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
S-ÏÙÜÕ¼×Áò°±ËáÍÑôÈø,S-adenosylmethionine decarboxylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½á³¦Ö±³¦°©,colorectal carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
DNAÐÞ¸´Ã¸Àà,DNA repair enzymesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÌÇÁòËáõ¥,polysaccharide sulfateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿Ë¡ÐÔ·ÖÎö,clonality analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÖÜÆÚ/Ò©Îï×÷ÓÃ,cell cycle/drug effectsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θÃÚËØÊÜÌå,gastrin receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ°°×ÖÊSurvivin,Protein SurvivinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ǰÁÐÏÙËáÐÔÁ×Ëáø,prostatic acid phosphataseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍλǰÇгýÊõ,Low anterior resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö±³¦ÏÙ°©,Rectal adenocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½áÖ±³¦Ö×Áö/Õï¶Ï,COLORECTAL NEOPLASMS/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±êÖ¾»ùÒò,marker geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÁÈÀÄ£ÐÍ,soil modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PCRоƬ,PCR ChipÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔöֳϵÊý,propagation coefficientÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HepG_2ϸ°û,HepG_2 cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾úÍÉ,bacterial ghostÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃâÒßÇ׺ÍÉ«Æ×,immunoaffinity chromatographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
˳²¬×¢ÉäÒº,Cisplatin injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
KAI1/CD82µ°°×,KAI1/CD82 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹ÜÔçÆÚ°©,early esophageal cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸´·¢×ªÒÆ,Recurrence and metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÕÆ¹ÑºËÜÕËá,Decoy oligonucleotideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PTENÁ×ËáË®½âø,PTEN phosphohydrolaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÕæºËÔØÌå,Eukaryotic vectorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Îϸ°û´Ì¼¤Òò×Ó,Hepatic stimulator substanceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°é°©×ÛºÏÕ÷,Paraneoplastic syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÒÖÖÆ,Cell inhibitionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×éµ°°×ÍÑÒÒõ£»ùø,histone deacetylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹ÜÖ×Áö/Á÷Ðв¡Ñ§,esophageal neoplasms/epidemiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²»¿ÉÄæÐÔµç»÷´©,irreversible electrical breakdownÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Áܰͻ¯ÁÆ,lymphatic chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Â-catenin»ùÒò,¦Â-catenin geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊÖÊõÇÐÔµ,Surgical marginÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÈÐݿ˵°°×gp96,Heat shock protein gp96Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÚºÏϸ°û,Fusion cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
˫Դ°©,concurrent cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÉìÕ¹,Cell spreadingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËáÂåÀÇú¿Ë,nolatrexed dihydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºÏÓÃÖ¸Êý,combination index(CI)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|